BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20123318)

  • 1. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.
    Aghel A; Shrestha K; Mullens W; Borowski A; Tang WH
    J Card Fail; 2010 Jan; 16(1):49-54. PubMed ID: 20123318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
    Elsharawy S; Raslan L; Morsy S; Hassan B; Khalifa N
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):49-54. PubMed ID: 26787566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
    Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure.
    De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL;
    Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure.
    Damman K; Valente MAE; van Veldhuisen DJ; Cleland JGF; O'Connor CM; Metra M; Ponikowski P; Cotter G; Davison B; Givertz MM; Bloomfield DM; Hillege HL; Voors AA
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure.
    Shrestha K; Shao Z; Singh D; Dupont M; Tang WH
    Am J Cardiol; 2012 Nov; 110(9):1329-35. PubMed ID: 22835414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study.
    Macdonald S; Arendts G; Nagree Y; Xu XF
    BMC Cardiovasc Disord; 2012 Feb; 12():8. PubMed ID: 22340728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil gelatinase-associated lipocalin predicts worsening of renal function in acute heart failure: methodological and clinical issues.
    Mortara A; Bonadies M; Mazzetti S; Fracchioni I; Delfino P; Chioffi M; Bersano C; Specchia G
    J Cardiovasc Med (Hagerstown); 2013 Sep; 14(9):629-34. PubMed ID: 23803723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.
    Maisel AS; Wettersten N; van Veldhuisen DJ; Mueller C; Filippatos G; Nowak R; Hogan C; Kontos MC; Cannon CM; Müller GA; Birkhahn R; Clopton P; Taub P; Vilke GM; McDonald K; Mahon N; Nuñez J; Briguori C; Passino C; Murray PT
    J Am Coll Cardiol; 2016 Sep; 68(13):1420-1431. PubMed ID: 27659464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.
    Maisel AS; Mueller C; Fitzgerald R; Brikhan R; Hiestand BC; Iqbal N; Clopton P; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Aug; 13(8):846-51. PubMed ID: 21791540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events.
    Collins SP; Hart KW; Lindsell CJ; Fermann GJ; Weintraub NL; Miller KF; Roll SN; Sperling MI; Sawyer DB; Storrow AB
    Eur J Heart Fail; 2012 Sep; 14(9):1020-9. PubMed ID: 22733980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.
    Alvelos M; Pimentel R; Pinho E; Gomes A; Lourenço P; Teles MJ; Almeida P; Guimarães JT; Bettencourt P
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):476-81. PubMed ID: 21115620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure.
    Breidthardt T; Socrates T; Drexler B; Noveanu M; Heinisch C; Arenja N; Klima T; Züsli C; Reichlin T; Potocki M; Twerenbold R; Steiger J; Mueller C
    Crit Care; 2012 Jan; 16(1):R2. PubMed ID: 22226205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.
    Wheeler DS; Devarajan P; Ma Q; Harmon K; Monaco M; Cvijanovich N; Wong HR
    Crit Care Med; 2008 Apr; 36(4):1297-303. PubMed ID: 18379258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
    Lukasz A; Beneke J; Menne J; Vetter F; Schmidt BM; Schiffer M; Haller H; Kümpers P; Kielstein JT
    Thromb Haemost; 2014 Feb; 111(2):365-72. PubMed ID: 24172823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neutrophil gelatinase-associated lipocalin as early biomarker for acute kidney injury in burn patients.
    Hong DY; Lee JH; Park SO; Baek KJ; Lee KR
    J Burn Care Res; 2013; 34(6):e326-32. PubMed ID: 23511281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis.
    Shapiro NI; Trzeciak S; Hollander JE; Birkhahn R; Otero R; Osborn TM; Moretti E; Nguyen HB; Gunnerson K; Milzman D; Gaieski DF; Goyal M; Cairns CB; Kupfer K; Lee SW; Rivers EP
    Ann Emerg Med; 2010 Jul; 56(1):52-59.e1. PubMed ID: 20363526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients.
    de Geus HR; Bakker J; Lesaffre EM; le Noble JL
    Am J Respir Crit Care Med; 2011 Apr; 183(7):907-14. PubMed ID: 20935115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.